Seiji Ohashi
Papers
1
Total Citations
53
H-Index
1
About
Seiji Ohashi is a leading investigator in diabetic nephropathy, with a focused expertise in the molecular mechanisms driving kidney damage in diabetes. His seminal work centers on the role of advanced glycation end products (AGEs) and their pathological effects on renal tissue. In his highly cited 2004 study, Ohashi demonstrated that AGEs upregulate HSP47, a collagen-specific chaperone protein, in a mouse model of diabetic nephropathy—a finding that has garnered 53 citations and reshaped understanding of fibrosis in diabetic kidneys. Crucially, he also showed that the AGE inhibitor OPB-9195 can suppress this HSP47 increase, offering a potential therapeutic avenue to prevent collagen accumulation and renal scarring. This contribution not only illuminated a key pathway in diabetic complications but also positioned Ohashi as a pioneer in targeting molecular chaperones for kidney disease. His work continues to influence researchers exploring anti-fibrotic strategies, bridging basic science with translational promise for millions affected by diabetes worldwide.
Research Focus
Key Achievements
Top Papers
- 1